Danaher Co. (NYSE:DHR) Shares Sold by Pratt Collard Advisory Partners LLC

Share on StockTwits

Pratt Collard Advisory Partners LLC lowered its holdings in Danaher Co. (NYSE:DHR) by 1.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,266 shares of the conglomerate’s stock after selling 220 shares during the period. Danaher comprises 1.9% of Pratt Collard Advisory Partners LLC’s holdings, making the stock its 15th biggest holding. Pratt Collard Advisory Partners LLC’s holdings in Danaher were worth $2,349,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in DHR. Next Capital Management LLC purchased a new position in shares of Danaher in the second quarter worth approximately $31,000. Litman Gregory Asset Management LLC purchased a new position in shares of Danaher in the second quarter worth approximately $33,000. Altshuler Shaham Ltd increased its position in shares of Danaher by 59.3% in the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 89 shares in the last quarter. Pinnacle Bank boosted its holdings in shares of Danaher by 52.3% during the third quarter. Pinnacle Bank now owns 262 shares of the conglomerate’s stock worth $38,000 after purchasing an additional 90 shares during the period. Finally, MRA Associates USA LLC acquired a new stake in shares of Danaher during the second quarter worth approximately $40,000. 78.44% of the stock is currently owned by institutional investors.

NYSE DHR traded down $0.01 during trading on Friday, reaching $137.76. The company’s stock had a trading volume of 55,673 shares, compared to its average volume of 2,241,212. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $98.70 billion, a PE ratio of 30.47, a PEG ratio of 2.30 and a beta of 0.94. The business has a 50-day moving average price of $141.27 and a 200-day moving average price of $137.60. Danaher Co. has a 1-year low of $94.59 and a 1-year high of $147.33.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.15 by $0.04. The firm had revenue of $5.16 billion during the quarter, compared to analysts’ expectations of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the company earned $1.15 earnings per share. As a group, analysts expect that Danaher Co. will post 4.78 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%. The ex-dividend date of this dividend is Thursday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 15.04%.

DHR has been the subject of several research reports. ValuEngine cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Robert W. Baird raised their price target on shares of Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Piper Jaffray Companies raised their price target on shares of Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a report on Thursday, July 18th. Needham & Company LLC restated a “buy” rating and set a $155.00 price target (up from $142.00) on shares of Danaher in a report on Friday, July 19th. Finally, Argus raised their price target on shares of Danaher to $165.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Danaher has an average rating of “Buy” and an average price target of $146.29.

In other Danaher news, insider Brian W. Ellis sold 1,010 shares of Danaher stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $144.04, for a total value of $145,480.40. Following the completion of the sale, the insider now directly owns 20,889 shares in the company, valued at $3,008,851.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Mitchell P. Rales bought 2,500 shares of Danaher stock in a transaction on Friday, August 23rd. The stock was acquired at an average price of $139.52 per share, with a total value of $348,800.00. Following the completion of the purchase, the chairman now directly owns 3,030,453 shares of the company’s stock, valued at $422,808,802.56. The disclosure for this purchase can be found here. Insiders sold 38,279 shares of company stock valued at $5,461,569 over the last quarter. Corporate insiders own 11.40% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: What is a support level?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Emerald Crypto Price Hits $0.0061 on Exchanges
Emerald Crypto Price Hits $0.0061 on Exchanges
Daiwa Securities Group Inc. Buys 11,500 Shares of Altice USA Inc
Daiwa Securities Group Inc. Buys 11,500 Shares of Altice USA Inc
Daiwa Securities Group Inc. Purchases 800 Shares of PACCAR Inc
Daiwa Securities Group Inc. Purchases 800 Shares of PACCAR Inc
Research Analysts’ Recent Ratings Updates for Barclays
Research Analysts’ Recent Ratings Updates for Barclays
-$0.14 Earnings Per Share Expected for Vascular Biogenics Ltd  This Quarter
-$0.14 Earnings Per Share Expected for Vascular Biogenics Ltd This Quarter
Eagle Asset Management Inc. Has $8.45 Million Holdings in Willdan Group, Inc.
Eagle Asset Management Inc. Has $8.45 Million Holdings in Willdan Group, Inc.


© 2006-2019 Ticker Report